New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For HITK;AEZS;AMED;IMGN;HTWR;CRVL;SQNM;MDAS;DSCI;CCRN From The Last 14 Days
Check below for free stories on HITK;AEZS;AMED;IMGN;HTWR;CRVL;SQNM;MDAS;DSCI;CCRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
14:41 EDTSQNMFDA draft lab tests guidelines not as bad as feared, says Piper Jaffray
Subscribe for More Information
08:00 EDTHTWRHeartWare reports Q2 EPS 49c, consensus (74c)
Subscribe for More Information
06:07 EDTAMEDAmedisys reported Q2 EPS 25c, consensus 13c
Subscribe for More Information
July 30, 2014
16:22 EDTMDASMedAssets sees FY14 EPS $1.32-$1.40, consensus $1.37
Subscribe for More Information
16:21 EDTMDASMedAssets reports Q2 EPS 30c, consensus 29c
Subscribe for More Information
09:47 EDTMDASLeerink healthcare analyst holds an analyst/industry conference call
Subscribe for More Information
08:39 EDTSQNMSequenom should be bought following solid Q2, says Maxim
Subscribe for More Information
July 29, 2014
18:35 EDTSQNMOn The Fly: After Hours Movers
Subscribe for More Information
16:33 EDTSQNMSequenom reports Q2 adjusted EPS (7c), consensus (11c)
Subscribe for More Information
16:32 EDTSQNMSequenom enters license agreement with Mayo Medical Laboratories
Subscribe for More Information
10:36 EDTHTWRThoratec drops after Wells Fargo cuts estimates, downgrades shares
Subscribe for More Information
July 25, 2014
07:30 EDTDSCIDerma Sciences sees sales of Medihoney dressings approaching $20M in 2014
July 22, 2014
09:03 EDTDSCIDerma Sciences says VA adds Amnioexcel to federal supply schedule
Subscribe for More Information
July 21, 2014
11:21 EDTSQNMSequenom VisibiliT launch unlikely to have near-term impact, says Ladenburg
Subscribe for More Information
07:02 EDTSQNMSequenom subsidiary launched VisibiliT test in international markets
Sequenom announced that its wholly owned subsidiary, Sequenom Laboratories, will soon launch the VisibiliT laboratory-developed test in international markets. The VisibiliT test utilizes maternal age, fetal fraction and the relative amount of chromosomal material for chromosomes 21 and 18 to generate a highly accurate, personalized risk score.
July 17, 2014
10:00 EDTAEZSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:04 EDTAEZSAeterna Zentaris initiated with a Buy at H.C. Wainwright
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use